TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/19/23 21:47 | 9/19/23 | NMRA | Neumora Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gosebruch Henry O | MA | DO | P,CEO | P | 189 | 12.62 | 0 | 15 | 3 | 525 | I | ||||||||||||||
5/11/23 21:06 | 5/9/23 | SLRN | Acelyrin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gosebruch Henry O | CA | D | P.d | 900 | 18.00 | 0 | 50 | New | 50 | D | |||||||||||||||
1/14/20 16:19 | 1/10/20 | APTX | Aptinyx Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gosebruch Henry O | IL | D | P | 75 | 3.00 | 0 | 25 | 25 | 125 | I | |||||||||||||||
7/31/19 16:46 | 7/29/19 | ABBV | Abbvie Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gosebruch Henry O | IL | O | EVP,Chie | P | 2,018 | 67.28 | 0 | 30 | 62 | 78 | D | ||||||||||||||
5/9/19 10:01 | 5/7/19 | APTX | Aptinyx Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gosebruch Henry O | IL | D | P.m | 386 | 3.86 | 0 | 100 | New | 100 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |